文献
J-GLOBAL ID:202202226476105478
整理番号:22A1055512
統合失調症-スペクトル障害におけるグルタミン酸作動性およびGABA作動性代謝産物レベル:1H-磁気共鳴スペクトロスコピー研究のメタ分析【JST・京大機械翻訳】
Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies
著者 (25件):
Nakahara Tomomi
(Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)
,
Tsugawa Sakiko
(Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)
,
Noda Yoshihiro
(Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)
,
Ueno Fumihiko
(Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)
,
Ueno Fumihiko
(Multimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada)
,
Honda Shiori
(Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)
,
Kinjo Megumi
(Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)
,
Segawa Hikari
(Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)
,
Hondo Nobuaki
(Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)
,
Mori Yukino
(Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)
,
Watanabe Honoka
(Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)
,
Nakahara Kazuho
(Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)
,
Yoshida Kazunari
(Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)
,
Yoshida Kazunari
(Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada)
,
Yoshida Kazunari
(Azrieli Adult Neurodevelopmental Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada)
,
Wada Masataka
(Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)
,
Tarumi Ryosuke
(Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)
,
Iwata Yusuke
(Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)
,
Plitman Eric
(Faculty of Medicine, University of Toronto, Toronto, ON, Canada)
,
Moriguchi Sho
(Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)
,
de la Fuente-Sandoval Camilo
(Laboratory of Experimental Psychiatry & Neuropsychiatry Department, Instituto Nacional de Neurologia y Neurocirugia, Mexico City, Mexico)
,
Uchida Hiroyuki
(Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)
,
Mimura Masaru
(Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)
,
Graff-Guerrero Ariel
(Multimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada)
,
Nakajima Shinichiro
(Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)
資料名:
Molecular Psychiatry
(Molecular Psychiatry)
巻:
27
号:
1
ページ:
744-757
発行年:
2022年
JST資料番号:
A1362A
ISSN:
1359-4184
資料種別:
逐次刊行物 (A)
記事区分:
文献レビュー
発行国:
ドイツ (DEU)
言語:
英語 (EN)